Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;27(5):1338-1347.
doi: 10.1245/s10434-020-08221-2. Epub 2020 Feb 28.

Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma

Affiliations
Review

Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma

Dhaval Patel et al. Ann Surg Oncol. 2020 May.

Abstract

This is the second part of a two-part review on pheochromocytoma and paragangliomas (PPGLs). In this part, perioperative management, including preoperative preparation, intraoperative, and postoperative interventions are reviewed. Current data on outcomes following resection are presented, including outcomes after cortical-sparing adrenalectomy for bilateral adrenal disease. In addition, pathological features of malignancy, surveillance considerations, and the management of advanced disease are also discussed.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
a Diagram outlining port placement for robotic retroperitoneoscopic approach to an adrenalectomy. b Patient prepped, draped, and ports placed for robotic retroperitoneal total adrenalectomy
FIG. 2
FIG. 2
Eleven-year-old male with VHL syndrome who underwent laparoscopic bilateral partial adrenalectomies guided with intraoperative ultrasound for bilateral pheochromocytomas. a Right adrenal tumor measuring 1.8 cm. b Post right partial adrenalectomy with preservation of the right adrenal vein. c Left adrenal tumor measuring 3.0 cm. d Post left partial adrenalectomy with preservation of the left adrenal vein. *Left and right adrenal tumors, respectively, ^Left and right adrenal veins, respectively, IVC inferior vena cava
FIG. 3
FIG. 3
A 59-year-old male with SDHB who underwent PRRT for progressive metastatic PPGL showing mild response after four cycles of treatment. a Baseline 68-gallium DOTATATE PET/CT scan showing widely metastatic disease. b 68-Gallium DOTATATE PET/CT scan showing mild tumor response after four cycles of Lutathera therapy

Similar articles

Cited by

References

    1. Goldstein RE, O’Neill JA Jr., Holcomb GW, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229(6):755–64 (discussion 764–756). - PMC - PubMed
    1. Kinney MA, Warner ME, van Heerden JA, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91(5):1118–1123. - PubMed
    1. Kercher KW, Novitsky YW, Park A, Matthews BD, Litwin DE, Heniford BT. Laparoscopic curative resection of pheochromocytomas. Ann Surg. 2005;241(6):919–26 (discussion 926–918). - PMC - PubMed
    1. Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr. Metyrosine and pheochromocytoma. Arch Intern Med. 1997;157(8):901–906. - PubMed
    1. Wachtel H, Kennedy EH, Zaheer S, et al. Preoperative metyrosine improves cardiovascular outcomes for patients undergoing surgery for pheochromocytoma and paraganglioma. Ann Surg Oncol. 2015;22 Suppl 3:S646–54. - PubMed

MeSH terms